Angiotensinogen is processed to angiotensin II which increases TGF-β playing an important role in the pathophysiology of cardiac fibrosis, heart failure and glomerulosclerosis in humans [59,60]. This evidence concerns the gene TGFB1 and glomerulosclerosis.